The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®

被引：0
作者：
F. Borgström
O. Ström
J. Coelho
H. Johansson
A. Oden
E. V. McCloskey
J. A. Kanis
机构：
[1] Karolinska Institute,Medical Management Centre
[2] I3 Innovus,undefined
[3] Centre for Metabolic Bone Diseases (WHO Collaborating Centre) University of Sheffield Medical School,undefined
来源：
Osteoporosis International | 2010年 / 21卷
关键词：
Cost-effectiveness; Fractures; FRAX; Osteoporosis; QALY;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：495 / 505
页数：10
相关论文
共 50 条
  • [21] Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
    Hiligsmann, M.
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (03) : 649 - 658
  • [22] Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
    Wan, Y.
    Zeng, F.
    Tan, H.
    Lu, Y.
    Zhang, Y.
    Zhao, L.
    You, R.
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (05) : 979 - 1015
  • [23] Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis
    M. Hiligsmann
    W. Ben Sedrine
    O. Bruyère
    J.-Y. Reginster
    Osteoporosis International, 2013, 24 : 2291 - 2300
  • [24] Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis
    Hiligsmann, M.
    Ben Sedrine, W.
    Bruyere, O.
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (08) : 2291 - 2300
  • [25] Intervention thresholds for denosumab in the UK using a FRAXA®-based cost-effectiveness analysis
    Strom, O.
    Jonsson, B.
    Kanis, J. A.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (04) : 1491 - 1502
  • [26] Cost-effectiveness research in osteoporosis
    Coyle, D
    Cranney, A
    Lee, KM
    Welch, V
    Tugwell, P
    DRUG DEVELOPMENT RESEARCH, 2000, 49 (03) : 135 - 140
  • [27] Cost-effectiveness of atypical antipsychotics for the management of schizophrenia in the UK
    Davies, Andrew
    Vardeva, Kawitha
    Loze, Jean-Yves
    L'Italien, Gilbert J.
    Sennfalt, Karin
    van Baardewijk, Marc
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3275 - 3285
  • [28] Cost-effectiveness of fracture prevention in established osteoporosis
    Jonsson, B
    Christiansen, C
    Johnell, O
    Hedbrandt, J
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1996, : 30 - 38
  • [29] COST-EFFECTIVENESS OF FRACTURE PREVENTION IN ESTABLISHED OSTEOPOROSIS
    JONSSON, B
    CHRISTIANSEN, C
    JOHNELL, O
    HEDBRANDT, J
    OSTEOPOROSIS INTERNATIONAL, 1995, 5 (02) : 136 - 142
  • [30] Risedronate versus alendronate in older patients with osteoporosis at high risk of fracture: an Italian cost-effectiveness analysis
    Berto, Patrizia
    Maggi, Stefania
    Noale, Marianna
    Lopatriello, Stefania
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 22 (02) : 179 - 188
12345